Albumin administration in the acutely ill: what is new and where next?
详细信息 查看全文
- 作者：Jean-Louis Vincent (21)
James A Russell (22)
Matthias Jacob (23)
Greg Martin (24)
Bertrand Guidet (25) (26)
Jan Wernerman (27)
Ricard Ferrer Roca (28)
Stuart A McCluskey (29)
Luciano Gattinoni (30)
21. Department of Intensive Care ; Erasme Hospital ; Universit茅 libre de Bruxelles ; route de Lennik 808 ; 1070 ; Brussels ; Belgium
22. Center for Heart Lung Innovation and Critical Care Medicine ; University of British Columbia and St. Paul鈥檚 Hospital ; Vancouver ; Canada ; V6Z BC
23. Department of Anaesthesiology ; University Hospital Munich ; Nussbaumstra脽e 20 ; 80336 ; Munich ; Germany
24. Department of Medicine ; Division of Pulmonary ; Allergy and Critical Care ; Emory University School of Medicine ; Atlanta ; GA ; 30303 ; USA
25. Service R茅animation M茅dicale ; H么pital Saint Antoine ; Universitaires Est Parisien ; Paris ; France
26. Sorbonne Universit茅s ; UPMC Universit茅 Paris 06 ; UMR-S 1136 ; Institut Pierre Louis d鈥橢pid茅miologie et de Sant茅 Publique ; F-75013 ; Paris ; France
27. Department of Anesthesiology & Intensive Care Medicine ; Karolinska University Hospital ; Huddinge ; 14186 ; Stockholm ; Sweden
28. Servei de Medicina Intensiva ; Hospital Universitari M煤tua Terrassa ; Universitat de Barcelona ; CIBER Enfermedades Respiratorias ; 08221 ; Terrassa ; Barcelona ; Spain
29. Department of Anesthesia and Pain Management ; Toronto General Hospital ; University of Toronto ; Toronto ; Ontario ; Canada ; M5G 2C4
30. Dipartimento di Anestesia ; Rianimazione (Intensiva e Subintensiva) e Terapia del Dolore ; Fondazione IRCCS Ca鈥?Granda 鈥?Ospedale Maggiore Policlinico ; 20122 ; Milan ; Italy - 刊名：Critical Care
- 出版年：2014
- 出版时间：August 2014
- 年：2014
- 卷：18
- 期：4
- 全文大小：595 KB
- 参考文献：1. Ancell, H (1839) Course of lectures on the physiology and pathology of the blood, and other animal fluids. Lancet 33: pp. 222-231 140-6736(02)83616-9" target="_blank" title="It opens in new window">CrossRef
Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 317: pp. 235-240 CrossRef
2. Vincent, JL (2009) Relevance of albumin in modern critical care medicine. Best Pract Res Clin Anaesthesiol 23: pp. 183-191 CrossRef
3. Finfer, S, Bellomo, R, McEvoy, S, Lo, SK, Myburgh, J, Neal, B, Norton, R (2006) Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 333: pp. 1044 CrossRef
4. Vincent, JL, Dubois, MJ, Navickis, RJ, Wilkes, MM (2003) Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 237: pp. 319-334
5. Laxenaire, MC, Charpentier, C, Feldman, L (1994) Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim 13: pp. 301-310 CrossRef
6. McClelland, DB (1998) Safety of human albumin as a constituent of biologic therapeutic products. Transfusion 38: pp. 690-699 CrossRef
Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med 170: pp. 1247-1259 CrossRef
7. Peters, T (1995) All About Albumin. Academic Press, San Diego
8. Fanali, G, di Masi, A, Trezza, V, Marino, M, Fasano, M, Ascenzi, P (2012) Human serum albumin: from bench to bedside. Mol Aspects Med 33: pp. 209-290 CrossRef
9. The Bovine and Human Albumin Programs [http://history.amedd.army.mil/booksdocs/wwii/blood/chapter12.htm]
10. Matejtschuk, P, Dash, CH, Gascoigne, EW (2000) Production of human albumin solution: a continually developing colloid. Br J Anaesth 85: pp. 887-895 CrossRef
11. Nicholson, JP, Wolmarans, MR, Park, GR (2000) The role of albumin in critical illness. Br J Anaesth 85: pp. 599-610 CrossRef
12. Fleck, A, Raines, G, Hawker, F, Trotter, J, Wallace, PI, Ledingham, IM, Calman, KC (1985) Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1: pp. 781-784 140-6736(85)91447-3" target="_blank" title="It opens in new window">CrossRef
13. Margarson, MP, Soni, N (1998) Serum albumin: touchstone or totem?. Anaesthesia 53: pp. 789-803 CrossRef
14. Woodcock, TE, Woodcock, TM (2012) Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 108: pp. 384-394 CrossRef
15. Jacob, M, Bruegger, D, Rehm, M, Stoeckelhuber, M, Welsch, U, Conzen, P, Becker, BF (2007) The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res 73: pp. 575-586 CrossRef
16. Adamson, RH, Lenz, JF, Zhang, X, Adamson, GN, Weinbaum, S, Curry, FE (2004) Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol 557: pp. 889-907 CrossRef
17. Jacob, M, Bruegger, D, Rehm, M, Welsch, U, Conzen, P, Becker, BF (2006) Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 104: pp. 1223-1231 CrossRef
18. Pries, AR, Secomb, TW, Gaehtgens, P (2000) The endothelial surface layer. Pflugers Arch 440: pp. 653-666 CrossRef
19. Zausig, YA, Chappell, D, Becker, BF, Potschka, D, Busse, H, Nixdorf, K, Bitzinger, D, Jacob, B, Jacob, M (2013) The impact of crystalloidal and colloidal infusion preparations on coronary vascular integrity, interstitial oedema and cardiac performance in isolated hearts. Crit Care 17: pp. R203 CrossRef
20. Chappell, D, Westphal, M, Jacob, M (2009) The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol 22: pp. 155-162 CrossRef
21. Jacob, M, Chappell, D (2013) Reappraising Starling: the physiology of the microcirculation. Curr Opin Crit Care 19: pp. 282-289 CrossRef
22. Roche, M, Rondeau, P, Singh, NR, Tarnus, E, Bourdon, E (2008) The antioxidant properties of serum albumin. FEBS Lett 582: pp. 1783-1787 CrossRef
23. Oettl, K, Stauber, RE (2007) Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 151: pp. 580-590 CrossRef
24. Taverna, M, Marie, AL, Mira, JP, Guidet, B (2013) Specific antioxidant properties of human serum albumin. Ann Intensive Care 3: pp. 4 CrossRef
25. Ulldemolins, M, Roberts, JA, Rello, J, Paterson, DL, Lipman, J (2011) The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet 50: pp. 99-110 CrossRef
26. Figge, J, Rossing, TH, Fencl, V (1991) The role of serum proteins in acid鈥揵ase equilibria. J Lab Clin Med 117: pp. 453-467
27. Jorgensen, KA, Stoffersen, E (1980) On the inhibitory effect of albumin on platelet aggregation. Thromb Res 17: pp. 13-18 CrossRef
28. Dubois, MJ, Orellana-Jimenez, C, Melot, C, De Backer, D, Berre, J, Leeman, M, Brimioulle, S, Appoloni, O, Creteur, J, Vincent, JL (2006) Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 34: pp. 2536-2540 CrossRef
29. Redelmeier, DA (2009) New thinking about postoperative hypoalbuminemia: a hypothesis of occult protein-losing enteropathy. Open Med 3: pp. e215-e219
30. Caironi, P, Gattinoni, L (2009) The clinical use of albumin: the point of view of a specialist in intensive care. Blood Transfus 7: pp. 259-267
31. Moshage, HJ, Janssen, JA, Franssen, JH, Hafkenscheid, JC, Yap, SH (1987) Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest 79: pp. 1635-1641 CrossRef
32. Barle, H, Hammarqvist, F, Westman, B, Klaude, M, Rooyackers, O, Garlick, PJ, Wernerman, J (2006) Synthesis rates of total liver protein and albumin are both increased in patients with an acute inflammatory response. Clin Sci (Lond) 110: pp. 93-99 CrossRef
33. Serra, R, Caroleo, S, Buffone, G, Lugara, M, Molinari, V, Tropea, F, Amantea, B, de Franciscis, S (2012) Low serum albumin level as an independent risk factor for the onset of pressure ulcers in intensive care unit patients. Int Wound J.
34. Al-Subaie, N, Reynolds, T, Myers, A, Sunderland, R, Rhodes, A, Grounds, RM, Hall, GM (2010) C-reactive protein as a predictor of outcome after discharge from the intensive care: a prospective observational study. Br J Anaesth 105: pp. 318-325 CrossRef
35. Wiedermann, CJ, Wiedermann, W, Joannidis, M (2010) Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensive Care Med 36: pp. 1657-1665 CrossRef
36. Lee, EH, Baek, SH, Chin, JH, Choi, DK, Son, HJ, Kim, WJ, Hahm, KD, Sim, JY, Choi, IC (2012) Preoperative hypoalbuminemia is a major risk factor for acute kidney injury following off-pump coronary artery bypass surgery. Intensive Care Med 38: pp. 1478-1486 CrossRef
37. Lyons, O, Whelan, B, Bennett, K, O'Riordan, D, Silke, B (2010) Serum albumin as an outcome predictor in hospital emergency medical admissions. Eur J Intern Med 21: pp. 17-20 CrossRef
38. Bernard, F, Al-Tamimi, YZ, Chatfield, D, Lynch, AG, Matta, BF, Menon, DK (2008) Serum albumin level as a predictor of outcome in traumatic brain injury: potential for treatment. J Trauma 64: pp. 872-875 CrossRef
39. Namendys-Silva, SA, Gonzalez-Herrera, MO, Texcocano-Becerra, J, Herrera-Gomez, A (2011) Hypoalbuminemia in critically ill patients with cancer: incidence and mortality. Am J Hosp Palliat Care 28: pp. 253-257 CrossRef
40. de la Cruz, KI, Bakaeen, FG, Wang, XL, Huh, J, LeMaire, SA, Coselli, JS, Chu, D (2011) Hypoalbuminemia and long-term survival after coronary artery bypass: a propensity score analysis. Ann Thorac Surg 91: pp. 671-675 CrossRef
41. Artero, A, Zaragoza, R, Camarena, JJ, Sancho, S, Gonzalez, R, Nogueira, JM (2010) Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. J Crit Care 25: pp. 276-281 CrossRef
42. Ranzani, OT, Zampieri, FG, Forte, DN, Azevedo, LC, Park, M (2013) C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PLoS One 8: pp. e59321 CrossRef
43. Gibbs, J, Cull, W, Henderson, W, Daley, J, Hur, K, Khuri, SF (1999) Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 134: pp. 36-42 CrossRef
44. Skillman, JJ, Restall, DS, Salzman, EW (1975) Randomized trial of albumin vs. electrolyte solutions during abdominal aortic operations. Surgery 78: pp. 291-303
45. Roberts, I, Edwards, P, McLelland, B (1999) More on albumin. Use of human albumin in UK fell substantially when systematic review was published. BMJ 318: pp. 1214-1215 14b" target="_blank" title="It opens in new window">CrossRef
The safety of human albumin. Curr Probl Pharmacovigilance 25: pp. 11
46. Finfer, S, Bellomo, R, Boyce, N, French, J, Myburgh, J, Norton, R (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350: pp. 2247-2256 CrossRef
47. Woodruff, LM, Gibson, ST (1942) The clinical evaluation of human albumin. US Naval Med Bull 40: pp. 791-796
48. Dear Doctor Letter 鈥?Albumin Use in Seriously Ill Patients [http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm105919.htm]
49. Sort, P, Navasa, M, Arroyo, V, Aldeguer, X, Planas, R, Ruiz-del-Arbol, L, Castells, L, Vargas, V, Soriano, G, Guevara, M, Gines, P, Rodes, J (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341: pp. 403-409 CrossRef
50. Wilkes, MM, Navickis, RJ (2001) Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 135: pp. 149-164 CrossRef
51. Finfer, S, McEvoy, S, Bellomo, R, McArthur, C, Myburgh, J, Norton, R (2011) Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 37: pp. 86-96 CrossRef
52. Myburgh, J, Cooper, DJ, Finfer, S, Bellomo, R, Norton, R, Bishop, N, Kai, LS, Vallance, S (2007) Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 357: pp. 874-884 14" target="_blank" title="It opens in new window">CrossRef
53. Safety of Albumin Administration in Critically Ill Patients [http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/BloodSafety/ucm095539.htm]
54. Vincent, JL, Sakr, Y, Reinhart, K, Sprung, CL, Gerlach, H, Ranieri, VM (2005) Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study. Crit Care 9: pp. R745-R754 CrossRef
55. Delaney, AP, Dan, A, McCaffrey, J, Finfer, S (2011) The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 39: pp. 386-391 CrossRef
56. Reinhart, K, Perner, A, Sprung, CL, Jaeschke, R, Schortgen, F, Johan Groeneveld, AB, Beale, R, Hartog, CS (2012) Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 38: pp. 368-383 CrossRef
57. Dellinger, RP, Levy, MM, Rhodes, A, Annane, D, Gerlach, H, Opal, SM, Sevransky, JE, Sprung, CL, Douglas, IS, Jaeschke, R, Osborn, TM, Nunnally, ME, Townsend, SR, Reinhart, K, Kleinpell, RM, Angus, DC, Deutschman, CS, Machado, FR, Rubenfeld, GD, Webb, SA, Beale, RJ, Vincent, JL, Moreno, R (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41: pp. 580-637 CrossRef
58. Charpentier, J, Mira, JP (2011) Efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study [abstract]. Intensive Care Med 37: pp. S115-0438
59. Caironi, P, Tognoni, G, Masson, S, Fumagalli, R, Pesenti, A, Romero, M, Fanizza, C, Caspani, L, Faenza, S, Grasselli, G, Iapichino, G, Antonelli, M, Parrini, V, Fiore, G, Latini, R, Gattinoni, L (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370: pp. 1412-1421 CrossRef
60. Cooper, DJ, Myburgh, J, Heritier, S, Finfer, S, Bellomo, R, Billot, L, Murray, L, Vallance, S (2013) Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality?. J Neurotrauma 30: pp. 512-518 CrossRef
61. Van Aken, HK, Kampmeier, TG, Ertmer, C, Westphal, M (2012) Fluid resuscitation in patients with traumatic brain injury: what is a SAFE approach?. Curr Opin Anaesthesiol 25: pp. 563-565 CrossRef
62. Martin, GS, Mangialardi, RJ, Wheeler, AP, Dupont, WD, Morris, JA, Bernard, GR (2002) Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 30: pp. 2175-2182 CrossRef
63. Martin, GS, Moss, M, Wheeler, AP, Mealer, M, Morris, JA, Bernard, GR (2005) A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 33: pp. 1681-1687 CrossRef
64. Gentilini, P, Casini-Raggi, V, Di Fiore, G, Romanelli, RG, Buzzelli, G, Pinzani, M, La Villa, G, Laffi, G (1999) Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 30: pp. 639-645 CrossRef
65. Doungngern, T, Huckleberry, Y, Bloom, JW, Erstad, B (2012) Effect of albumin on diuretic response to furosemide in patients with hypoalbuminemia. Am J Crit Care 21: pp. 280-286 CrossRef
66. Guevara, M, Terra, C, Nazar, A, Sola, E, Fernandez, J, Pavesi, M, Arroyo, V, Gines, P (2012) Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. J Hepatol 57: pp. 759-765 CrossRef
67. Kwok, CS, Krupa, L, Mahtani, A, Kaye, D, Rushbrook, SM, Phillips, MG, Gelson, W (2013) Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis. Biomed Res Int 2013: pp. 295153
68. Martin-Llahi, M, Pepin, MN, Guevara, M, Diaz, F, Torre, A, Monescillo, A, Soriano, G, Terra, C, Fabrega, E, Arroyo, V, Rodes, J, Gines, P (2008) Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 134: pp. 1352-1359 CrossRef
69. Neri, S, Pulvirenti, D, Malaguarnera, M, Cosimo, BM, Bertino, G, Ignaccolo, L, Siringo, S, Castellino, P (2008) Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome. Dig Dis Sci 53: pp. 830-835 CrossRef
70. Rivers, E, Nguyen, B, Havstad, S, Ressler, J, Muzzin, A, Knoblich, B, Peterson, E, Tomlanovich, M (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: pp. 1368-1377 CrossRef
71. Wiedermann, CJ, Joannidis, M (2014) Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review. Intensive Care Med 40: pp. 160-170 CrossRef
72. Perner, A, Haase, N, Guttormsen, AB, Tenhunen, J, Klemenzson, G, Aneman, A, Madsen, KR, Moller, MH, Elkjaer, JM, Poulsen, LM, Bendtsen, A, Winding, R, Steensen, M, Berezowicz, P, Soe-Jensen, P, Bestle, M, Strand, K, Wiis, J, White, JO, Thornberg, KJ, Quist, L, Nielsen, J, Andersen, LH, Holst, LB, Thormar, K, Kjaeldgaard, AL, Fabritius, ML, Mondrup, F, Pott, FC, Moller, TP (2012) Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 367: pp. 124-134 CrossRef
73. Rehm, M, Orth, V, Kreimeier, U, Thiel, M, Haller, M, Brechtelsbauer, H, Finsterer, U (2000) Changes in intravascular volume during acute normovolemic hemodilution and intraoperative retransfusion in patients with radical hysterectomy. Anesthesiology 92: pp. 657-664 CrossRef
74. Jacob, M, Chappell, D, Hofmann-Kiefer, K, Helfen, T, Schuelke, A, Jacob, B, Burges, A, Conzen, P, Rehm, M (2012) The intravascular volume effect of Ringer's lactate is below 20%: a prospective study in humans. Crit Care 16: pp. R86 CrossRef
75. Yunos, NM, Bellomo, R, Hegarty, C, Story, D, Ho, L, Bailey, M (2012) Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 308: pp. 1566-1572 CrossRef
76. Ernest, D, Belzberg, AS, Dodek, PM (1999) Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 27: pp. 46-50 CrossRef
77. Farrugia, A (2010) Albumin usage in clinical medicine: tradition or therapeutic?. Transfus Med Rev 24: pp. 53-63 CrossRef
78. Bar-Or, D, Bar-Or, R, Rael, LT, Gardner, DK, Slone, DS, Craun, ML (2005) Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit Care Med 33: pp. 1638-1641 14858.91" target="_blank" title="It opens in new window">CrossRef
79. Martin, GS (2005) Pharmacological aspects of albumin as a niche product in the intensive care unit. Crit Care Med 33: pp. 1667-1669 CrossRef
80. Vincent, JL, Wilkes, MM, Navickis, RJ (2003) Safety of human albumin 鈥?serious adverse events reported worldwide in 1998鈥?000. Br J Anaesth 91: pp. 625-630 CrossRef
81. Barron, ME, Wilkes, MM, Navickis, RJ (2004) A systematic review of the comparative safety of colloids. Arch Surg 139: pp. 552-563 CrossRef
82. Groeneveld, AB, Navickis, RJ, Wilkes, MM (2011) Update on the comparative safety of colloids: a systematic review of clinical studies. Ann Surg 253: pp. 470-483 CrossRef
83. Guidet, B, Mosqueda, GJ, Priol, G, Aegerter, P (2007) The COASST study: cost-effectiveness of albumin in severe sepsis and septic shock. J Crit Care 22: pp. 197-203 CrossRef
84. Farrugia, A, Bansal, M, Balboni, S, Kimber, MC, Martin, GS, Cassar, J (2013) Choice of fluids in severe septic patients 鈥?a cost-effectiveness analysis informed by recent clinical trials. Rev Recent Clin Trials.
85. Vincent, JL, Fink, MP, Marini, JJ, Pinsky, MR, Sibbald, WJ, Singer, M, Suter, PM, Cook, D, Pepe, PE, Evans, T (2006) Intensive care and emergency medicine: progress over the past 25 years. Chest 129: pp. 1061-1067 CrossRef
86. Salerno, F, Gerbes, A, Gines, P, Wong, F, Arroyo, V (2007) Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56: pp. 1310-1318 - 刊物主题：Intensive / Critical Care Medicine; Emergency Medicine;
- 出版者：BioMed Central
- ISSN：1364-8535
文摘
Albumin solutions have been used worldwide for the treatment of critically ill patients since they became commercially available in the 1940s. However, their use has become the subject of criticism and debate in more recent years. Importantly, all fluid solutions have potential benefits and drawbacks. Large multicenter randomized studies have provided valuable data regarding the safety of albumin solutions, and have begun to clarify which groups of patients are most likely to benefit from their use. However, many questions remain related to where exactly albumin fits within our fluid choices. Here, we briefly summarize some of the physiology and history of albumin use in intensive care before offering some evidence-based guidance for albumin use in critically ill patients.